Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206071
Company: NAVINTA LLC

Products on ANDA 206071

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206071

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/24/2017	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206071Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 206071

METHOCARBAMOL

SOLUTION;IM-IV; 1GM/10ML (100MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	207496	AM REGENT
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	206128	EUGIA PHARMA
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	209331	FRESENIUS KABI USA
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	211504	GLAND PHARMA LTD
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	205354	MONTEREY PHARMS LLC
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	206071	NAVINTA LLC
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	205404	SAGENT PHARMS INC
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	208116	SLATE RUN PHARMA
METHOCARBAMOL	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	No	AP	207522	SOMERSET THERAPS LLC
ROBAXIN	METHOCARBAMOL	1GM/10ML (100MG/ML)	SOLUTION;IM-IV	Prescription	Yes	AP	011790	HIKMA